Creative Touch Permanent Makeup and Aesthetics

PRF’s clinical superiority to PRP in skin regeneration applications rests on two mechanistic distinctions: the fibrin matrix architecture that converts an acute growth factor burst into a sustained tissue signal, and the higher leukocyte concentration that adds immunomodulatory and pro-regenerative signals absent from standard PRP preparations. In comparative fibroblast studies, fluid PRF produces approximately twice the collagen type I staining of PRP, with markedly higher TGF-β1, collagen I, and fibronectin mRNA expression – the growth factor signal is not only more sustained but cumulatively more potent. ^[1] The PRF family encompasses multiple preparation formats – solid PRF membranes/gel, leukocyte-rich L-PRF, and injectable i-PRF – each with distinct fibrin architecture and clinical application profiles, unified by the absence of anticoagulant and the central role of fibrinogen-to-fibrin conversion in their mechanism.

The Fibrin Matrix: What Makes PRF Mechanically and Biologically Distinct

The fundamental distinction between PRF and PRP is not concentration but architecture. PRP is a liquid preparation: when activated (by calcium chloride, thrombin, or tissue contact), platelets release their alpha granule contents immediately, delivering a high-concentration growth factor burst that is largely dissipated within 15 minutes. ^[1] PRF, prepared without anticoagulant, allows thrombin generated endogenously during centrifugation to begin converting fibrinogen to fibrin before and during the separation process. The resulting fibrin network physically entraps platelets, leukocytes, and their secreted growth factors within a three-dimensional polymer scaffold.

Growth factor release from this fibrin matrix occurs as the fibrin is enzymatically degraded in vivo – a process that takes 7–14 days rather than minutes. The clinical consequence is that PRF delivers a sustained tissue signal across the collagen remodelling timeframe rather than an acute pulse that the tissue must respond to within a narrow window. TGF-β1, PDGF, VEGF, IGF-1, and EGF are all released across this extended period, maintaining fibroblast activation, angiogenesis, and matrix remodelling signals simultaneously.

The fibrin matrix itself has structural value beyond growth factor retention. It provides a physical scaffold that supports cell migration and attachment at the treatment site – a property that solid PRF preparations exploit for wound healing applications, and that contributes to the volumising and lifting effects observed with injectable fluid PRF in clinical comparisons. ^[1]

The PRF Family: Preparation Formats and Distinctions

PRF encompasses several preparation variants that share the anticoagulant-free, fibrin-matrix principle but differ in centrifugation protocol, leukocyte content, and physical form:

L-PRF (Leukocyte- and Platelet-Rich Fibrin): The original Choukroun protocol, producing a solid membrane or plug suitable for surgical wound coverage and socket regeneration. High centrifugation speed concentrates leukocytes alongside platelets; the resulting solid fibrin structure is not injectable but is directly applicable to wound sites.

A-PRF (Advanced PRF): A lower-speed modification of L-PRF that retains more leukocytes and produces a denser fibrin network with higher growth factor content per unit volume. Still solid/gel form.

i-PRF / iPRF (Injectable PRF): The liquid form produced by very low centrifugation speed and short duration, which slows fibrin polymerisation sufficiently that the preparation remains injectable. iPRF retains the leukocyte and platelet concentration advantage over PRP while remaining in a form suitable for intradermal injection or topical application during microneedling. It is not a gel – it is liquid plasma with concentrated platelets and leukocytes that will begin fibrin polymerisation at the treatment site following injection, transitioning from liquid to early fibrin network in vivo. ^[2]

Solid PRF / PRF gel: Produced at intermediate speeds, yielding a cohesive gel suitable for injection into deeper tissue planes – used for volumising applications where the physical structure of the fibrin contributes to tissue support alongside the growth factor payload.

The centrifugation protocol is therefore not a minor technical detail – it determines which PRF format is produced and what physical and biological properties the final preparation carries. Horizontal centrifugation has demonstrated superior platelet and leukocyte accumulation compared to fixed-angle centrifuges across multiple PRF protocols. ^[2]

PRF vs PRP: The Comparative Evidence

The clinical rationale for choosing PRF over PRP in skin regeneration applications has direct primary literature support. In human skin fibroblast comparative studies, fluid PRF produced markedly higher TGF-β1 and collagen I mRNA expression than PRP, and approximately twice the collagen type I protein staining in cell culture models. ^[1] Fibronectin expression – relevant to cell adhesion, migration, and matrix organisation – was also significantly higher in PRF-treated fibroblasts.

In a clinical comparison for atrophic acne scar treatment, the PRF group showed greater improvement in skin texture and laxity, with the improvement appearing earlier than in the PRP group. The intradermal injection of fluid PRF produced a notable filling and lifting effect from day two post-treatment, maintained for up to two weeks – attributed to the physical volume of the fibrin matrix forming in situ, before the growth factor-driven collagen remodelling timeline begins. ^[1]

The mechanistic explanation for PRF’s quantitative advantage over PRP is the leukocyte content. Leukocytes – particularly macrophages and neutrophils retained in PRF – contribute additional growth factors and cytokines to the matrix, and macrophage polarisation within the fibrin scaffold toward M2 (anti-inflammatory, pro-regenerative) phenotype drives the TGF-β and VEGF signalling that PRP platelet content alone does not generate to the same degree.

Growth Factor Profile

The growth factors delivered by PRF are released from two sources: platelet alpha granules and leukocyte secretion. The primary regenerative signals include:

• TGF-β1 – primary driver of fibroblast procollagen synthesis via SMAD2/3; markedly higher in PRF than PRP preparations
• PDGF (Platelet-Derived Growth Factor) – fibroblast proliferation and migration; present in both PRF and PRP at comparable concentrations
• VEGF (Vascular Endothelial Growth Factor) – angiogenesis; new vessel formation supports oxygen and nutrient delivery to remodelling tissue
• IGF-1 (Insulin-like Growth Factor 1) – fibroblast and keratinocyte proliferation; matrix synthesis support
• EGF (Epidermal Growth Factor) – keratinocyte proliferation and re-epithelialisation; relevant to surface renewal alongside dermal remodelling
• FGF (Fibroblast Growth Factor) – fibroblast and keratinocyte mitogen; supports both dermal and epidermal renewal